Ethyol Related Clinical Trials
Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities [Completed]
Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia [Active, not recruiting]
Amifostine for Head and Neck Irradiation in Lymphoma [Active, not recruiting]
Determination of Amifostine Levels During Radiation Therapy [Completed]
Subcutaneous Amifostine Safety Study [Completed]
Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer [Completed]
Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer [Active, not recruiting]
EVALUATION OF AMIFOSTINE FOR MUCOSAL AND HEMOPOETIC PROTECTION AND CARBOPLATIN, TAXOL, RADIOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH HEAD AND NECK CANCER. [Completed]
Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome [Completed]
A Study of Amifostine (Ethyol) in Patients With Colorectal Cancer [Recruiting]
Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer Treatment [Recruiting]
Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome [Active, not recruiting]
Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome [Active, not recruiting]
Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy [Completed]
Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors [Active, not recruiting]
Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation [Completed]
Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer [Active, not recruiting]
Amifostine and High-Dose Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Chronic Myelogenous Leukemia [Active, not recruiting]
Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Active, not recruiting]
Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer [Active, not recruiting]
Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma [Recruiting]
Chemotherapy and Radiation Therapy With or Without Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Active, not recruiting]
Intravenous Versus Subcutaneous Amifostine in Prevention of Xerostomia After RT for Head and Neck Carcinomas [Completed]
Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer [No longer recruiting]
Amifostine in Treating Patients With Myelodysplastic Syndrome [Active, not recruiting]
Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II or Stage III Multiple Myeloma [Recruiting]
Radiation Therapy and Cisplatin With or Without Amifostine in Treating Patients With Stage IIIB or Stage IVA Cancer of the Cervix [Active, not recruiting]
Amifostine in Protecting the Rectum in Patients Undergoing Radiation Therapy for Prostate Cancer [Active, not recruiting]
Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy [Active, not recruiting]
Phase III of Unilateral Neck Irradiation With Amifostine in Patients With SCC of the Head and Neck [Recruiting]
Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes [Completed]
Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors [Completed]
Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome [Active, not recruiting]
Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer [Active, not recruiting]
Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Completed]
Combination Chemotherapy Plus Amifostine in Treating Patients With Metastatic or Unresectable Cancer [Active, not recruiting]
Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer [Completed]
Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer [Active, not recruiting]
Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer [Active, not recruiting]
Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors [Active, not recruiting]
Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer [Active, not recruiting]
Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors [Active, not recruiting]
Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer [Active, not recruiting]
Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer [Completed]
Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation [Active, not recruiting]
Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-Small Cell Lung Cancer [Active, not recruiting]
Amifostine to Protect From the Side Effects of Peripheral Stem Cell Transplantation in Treating Patients With High-Risk or Relapsed Solid Tumors [Active, not recruiting]
Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors [Active, not recruiting]
Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer [Active, not recruiting]
Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer [Active, not recruiting]
Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx [Active, not recruiting]
Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer [Active, not recruiting]
Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer [Completed]
Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-Small Cell Lung Cancer [No longer recruiting]
Radiation Therapy, Carboplatin, and Paclitaxel With or Without Amifostine in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer [Recruiting]
Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer [Terminated]
Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy [No longer recruiting]
Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome [No longer recruiting]
High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation and Chemoprotective Therapy in Treating Patients With Cancer [No longer recruiting]
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer [Recruiting]
Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia [No longer recruiting]
High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer [Active, not recruiting]
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer [No longer recruiting]
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia [Active, not recruiting]
Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate [Active, not recruiting]
Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer [No longer recruiting]
Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck [Recruiting]
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer [Completed]
Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer [No longer recruiting]
Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer [No longer recruiting]
Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor [Completed]
Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor [No longer recruiting]
Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery [No longer recruiting]
|
